These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 8895983)
1. Genetic susceptibility to tumor progression in mouse skin carcinogenesis. Stern MC; Conti CJ Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983 [No Abstract] [Full Text] [Related]
2. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis. La E; Muga SJ; Locniskar MF; Fischer SM Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864 [TBL] [Abstract][Full Text] [Related]
3. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains. Stern MC; Benavides F; LaCava M; Conti CJ Mol Carcinog; 2002 Sep; 35(1):13-20. PubMed ID: 12203363 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
5. Two-stage tumor promotion in mouse skin: an alternative interpretation. Hennings H; Yuspa SH J Natl Cancer Inst; 1985 Apr; 74(4):735-40. PubMed ID: 3921746 [No Abstract] [Full Text] [Related]
6. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis. DiGiovanni J; Rho O; Xian W; Beltràn L Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243 [TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis. Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585 [TBL] [Abstract][Full Text] [Related]
8. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development. Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598 [TBL] [Abstract][Full Text] [Related]
9. Allelotype analysis of chemically induced squamous cell carcinomas in F(1) hybrids of two inbred mouse strains with different susceptibility to tumor progression. Stern MC; Benavides F; Klingelberger EA; Conti CJ Carcinogenesis; 2000 Jul; 21(7):1297-301. PubMed ID: 10874006 [TBL] [Abstract][Full Text] [Related]
10. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin. Hennings H; Lowry DT; Yuspa SH; Mock B; Potter M Mol Carcinog; 1997 Sep; 20(1):143-50. PubMed ID: 9328445 [TBL] [Abstract][Full Text] [Related]
11. Differential gene expression during tumor promotion and progression in the mouse skin model. Bowden GT; Ostrowski LE; Bonham K; Krieg P Basic Life Sci; 1991; 57():127-40; discussion 140-1. PubMed ID: 1667569 [No Abstract] [Full Text] [Related]
12. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Woodworth CD; Michael E; Smith L; Vijayachandra K; Glick A; Hennings H; Yuspa SH Carcinogenesis; 2004 Sep; 25(9):1771-8. PubMed ID: 15105299 [TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of multistage hepatocarcinogenesis. Poole TM; Chiaverotti TA; Carabeo RA; Drinkwater NR Prog Clin Biol Res; 1996; 395():33-45. PubMed ID: 8895982 [No Abstract] [Full Text] [Related]
14. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen. Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659 [TBL] [Abstract][Full Text] [Related]
15. Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin. Hennings H Basic Life Sci; 1991; 57():31-9; discussion 39-42. PubMed ID: 1814291 [TBL] [Abstract][Full Text] [Related]
16. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Hennings H; Devor D; Wenk ML; Slaga TJ; Former B; Colburn NH; Bowden GT; Elgjo K; Yuspa SH Cancer Res; 1981 Mar; 41(3):773-9. PubMed ID: 6780187 [TBL] [Abstract][Full Text] [Related]
17. [p53 gene mutations in mouse skin tumors induced by DMBA-TPA-MNNG]. Zhang S; Guo ; Klein-Szanto A Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):298-300. PubMed ID: 11245002 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion. Reiners JJ; Singh KP Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561 [TBL] [Abstract][Full Text] [Related]
19. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol. Kiguchi K; Beltrán L; Rupp T; DiGiovanni J Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251 [TBL] [Abstract][Full Text] [Related]
20. Sensitivity to two-stage carcinogenesis of SENCAR mouse skin grafted to nude mice. Yuspa SH; Spangler EF; Donahoe R; Geusz S; Ferguson E; Wenk M; Hennings H Cancer Res; 1982 Feb; 42(2):437-9. PubMed ID: 6799187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]